GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the complex between ppargamma lbd and the ligand NV1362 (7A)

Analyse Crystal structure of the complex between ppargamma lbd and the ligand NV1362… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6ZLY
Type
protein
Length
496 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
QMH
Pockets
7 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25269% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein24468% helix, 5% strandP37231

Ligands and binding sites

  • QMH · (2~{S})-2-[(4-hexoxyphenyl)carbonylamino]-3-methyl-butanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14940.780.8556QMH
24660.750.8356empty
33650.690.8238empty
41090.570.8522empty
52050.490.7620empty

Interfaces

1 interface between chains.

  • A–B · 1138 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 6ZLY · Crystal structure of the complex between PPARgamma LBD and the ligand NV1362 (7a) · the same entry in another collection · chain A against A, TM-score 1.00
  • P37231 · AlphaFold monomer V2.0 prediction for peroxisome proliferator- activated receptor gamma… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.